Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

SARS-CoV-2 antigen rapid diagnostic test enhanced with silver amplification technology

Kei Miyakawa, Rikako Funabashi, Yutaro Yamaoka, Sundararaj Stanleyraj Jeremiah, Junichi Katada, Atsuhiko Wada, Toshiki Takei, Kohei Shimizu, Hiroki Ozawa, Chiharu Kawakami, Shuzo Usuku, Nobuko Tanaka, Etsuko Yamazaki, Hideaki Shimizu, Nobuhiko Okabe, Hideki Hasegawa, Akihide Ryo
doi: https://doi.org/10.1101/2021.01.27.21250659
Kei Miyakawa
1Department of Microbiology, Yokohama City University School of Medicine, Kanagawa 236-0004, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rikako Funabashi
1Department of Microbiology, Yokohama City University School of Medicine, Kanagawa 236-0004, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yutaro Yamaoka
1Department of Microbiology, Yokohama City University School of Medicine, Kanagawa 236-0004, Japan
2Life Science Laboratory, Technology and Development Division, Kanto Chemical Co., Inc., Kanagawa 259-1146, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sundararaj Stanleyraj Jeremiah
1Department of Microbiology, Yokohama City University School of Medicine, Kanagawa 236-0004, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Junichi Katada
3Medical Systems Research & Development Center, FUJIFILM Corporation, Kanagawa 258-8538, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Atsuhiko Wada
3Medical Systems Research & Development Center, FUJIFILM Corporation, Kanagawa 258-8538, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toshiki Takei
3Medical Systems Research & Development Center, FUJIFILM Corporation, Kanagawa 258-8538, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kohei Shimizu
4Yokohama City Institute of Public Health, Kanagawa, 236-0051, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroki Ozawa
4Yokohama City Institute of Public Health, Kanagawa, 236-0051, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chiharu Kawakami
4Yokohama City Institute of Public Health, Kanagawa, 236-0051, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shuzo Usuku
4Yokohama City Institute of Public Health, Kanagawa, 236-0051, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nobuko Tanaka
4Yokohama City Institute of Public Health, Kanagawa, 236-0051, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Etsuko Yamazaki
5Clinical Laboratory Department, Yokohama City University Hospital, Kanagawa 236-0004, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hideaki Shimizu
6Division of Virology, Kawasaki City Institute for Public Health, Kanagawa, 210-0821, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nobuhiko Okabe
6Division of Virology, Kawasaki City Institute for Public Health, Kanagawa, 210-0821, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hideki Hasegawa
7Influenza Research Center, National Institute of Infectious Diseases, Tokyo 208-0011, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akihide Ryo
1Department of Microbiology, Yokohama City University School of Medicine, Kanagawa 236-0004, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: aryo@yokohama-cu.ac.jp
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Rapid diagnosis of COVID-19 is essential for instituting measures to prevent viral spread. SARS-CoV-2 antigen rapid diagnostic test (Ag-RDT) based on lateral flow immunochromatography assay (LFIA) principle can visually indicate the presence of SARS-CoV-2 antigens as a band. Ag-RDT is clinically promising as a point-of-care testing because it can give results in a short time without the need for special equipment. Although various antigen capture LFIAs are now available for rapid diagnosis for SARS-CoV-2 infection, they face the problems of low sensitivity. We have previously developed highly specific monoclonal antibodies (mAb) against SARS-CoV-2 nucleocapsid protein (NP) and in this study, we have employed these mAbs to develop a new LFIA that can detect SARS-CoV-2 NP in nasopharyngeal swab samples with higher sensitivity by combining them with silver amplification technology. We also compared the performance of our Ag-RDT against the commercially available Ag-RDTs using clinical samples to find that our newly developed LFIA performed best among tested, highlighting the superiority of silver amplification technology.

Competing Interest Statement

YY is an employee of Kanto Chemical Co., Inc.; JK, AW, and TT are current employee of FUJIFILM Corporation.; Remaining authors declare that they have no competing interests.

Funding Statement

This work was supported in part by Japan Agency for Medical Research and Development (AMED, Grant numbers JP19fk0108110 and JP20he0522001), and by Health Labour Sciences research grant from The Ministry of Health Labour and Welfare (Grant number 19HA1003) to AR.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study protocol was approved by the IRB of Yokohama City University (B200800106).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All relevant data are available from the authors on request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted January 31, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
SARS-CoV-2 antigen rapid diagnostic test enhanced with silver amplification technology
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
SARS-CoV-2 antigen rapid diagnostic test enhanced with silver amplification technology
Kei Miyakawa, Rikako Funabashi, Yutaro Yamaoka, Sundararaj Stanleyraj Jeremiah, Junichi Katada, Atsuhiko Wada, Toshiki Takei, Kohei Shimizu, Hiroki Ozawa, Chiharu Kawakami, Shuzo Usuku, Nobuko Tanaka, Etsuko Yamazaki, Hideaki Shimizu, Nobuhiko Okabe, Hideki Hasegawa, Akihide Ryo
medRxiv 2021.01.27.21250659; doi: https://doi.org/10.1101/2021.01.27.21250659
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
SARS-CoV-2 antigen rapid diagnostic test enhanced with silver amplification technology
Kei Miyakawa, Rikako Funabashi, Yutaro Yamaoka, Sundararaj Stanleyraj Jeremiah, Junichi Katada, Atsuhiko Wada, Toshiki Takei, Kohei Shimizu, Hiroki Ozawa, Chiharu Kawakami, Shuzo Usuku, Nobuko Tanaka, Etsuko Yamazaki, Hideaki Shimizu, Nobuhiko Okabe, Hideki Hasegawa, Akihide Ryo
medRxiv 2021.01.27.21250659; doi: https://doi.org/10.1101/2021.01.27.21250659

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (431)
  • Anesthesia (99)
  • Cardiovascular Medicine (940)
  • Dentistry and Oral Medicine (178)
  • Dermatology (109)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (418)
  • Epidemiology (8967)
  • Forensic Medicine (4)
  • Gastroenterology (417)
  • Genetic and Genomic Medicine (1938)
  • Geriatric Medicine (190)
  • Health Economics (400)
  • Health Informatics (1320)
  • Health Policy (657)
  • Health Systems and Quality Improvement (517)
  • Hematology (211)
  • HIV/AIDS (416)
  • Infectious Diseases (except HIV/AIDS) (10764)
  • Intensive Care and Critical Care Medicine (570)
  • Medical Education (199)
  • Medical Ethics (52)
  • Nephrology (221)
  • Neurology (1815)
  • Nursing (108)
  • Nutrition (271)
  • Obstetrics and Gynecology (351)
  • Occupational and Environmental Health (469)
  • Oncology (992)
  • Ophthalmology (296)
  • Orthopedics (111)
  • Otolaryngology (182)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (576)
  • Pharmacology and Therapeutics (275)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1891)
  • Public and Global Health (4107)
  • Radiology and Imaging (674)
  • Rehabilitation Medicine and Physical Therapy (361)
  • Respiratory Medicine (547)
  • Rheumatology (224)
  • Sexual and Reproductive Health (190)
  • Sports Medicine (177)
  • Surgery (206)
  • Toxicology (38)
  • Transplantation (109)
  • Urology (80)